CRS03
Mastering Revenue Recognition for Biotech Licensing Deals
Master revenue recognition strategies for complex pharmaceutical, Med-Tech, and Biotech licensing arrangements involving milestones, royalties, and multi-territory structures while maintaining IFRS 15 compliance.
Course overview
What you will learn
- Understand the complete out-licensing deal landscape and terminology.
- Apply the five-step IFRS 15 framework systematically.
- Distinguish between customer and collaborator relationships.
- Identify contracts that qualify for IFRS 15 treatment.
- Assess contract terms, duration, and modification requirements.
- Evaluate when multiple contracts should be combined.
- Apply the two-part ‘distinct’ criteria to pharmaceutical arrangements.
- Distinguish between right-to-use and right-to-access licensing structures.
- Estimate variable consideration using expected value and most likely amount methods.
- Apply revenue constraint principles to milestone payments.
- Calculate stand-alone selling prices using multiple estimation methods.
- Implement royalty recognition rules and sales-based exemptions.
- Distinguish between principal and agent relationships in distribution deals.
- Develop robust documentation processes for audit compliance.
Why you should attend
Finance professionals in Pharma, Biotech, and Med-Tech need a deep understanding of the accounting implications of licensing deals in this specialised sector. This course provides a systematic framework for anticipating and managing revenue recognition issues while maintaining IFRS 15 compliance.
Real-life cases and interactive sessions provide actionable insights and help consolidate knowledge. Live courses are limited to 10 participants, creating opportunities to ask specific questions and share experiences with international peers.
Additional benefits
- Access expert guidance on your active deals.
- Engage in peer learning through pre-course questionnaires and live polling.
- Apply concepts through real-life case studies in small group settings.
- Learn from experienced and enthusiastic instructors.
- Benefit from clear, simplified communication.
- Acquire transferable knowledge for related business transactions.
Who should attend?
- Finance Directors & Controllers in pharmaceutical companies.
- Revenue Recognition Specialists handling complex licensing deals.
- Business Development Managers structuring partnership agreements.
- Internal Auditors reviewing revenue recognition processes.
- Legal Counsel involved in licensing negotiations.
Executives from other professional service agencies should request approval before registering. Please contact sales@mioconsult.com.
Your instructor
Meet Michelle Olufeso-Nwokobia
Founder & CEO
Former Head of Accounting External Relations & Global Alliances at a Swiss pharmaceutical firm, with more than 15 years specialising in pharmaceutical accounting. Expertise includes licensing deals, business combinations, and IFRS implementation, with experience across Oil & Gas, Telecoms, and Financial Services.
Course dates
Choose how you would like to attend
Each course instance is linked to its delivery type. Confirmed dates will appear here as soon as they are published.
Published course times use Europe/Berlin time.
Self-paced
Learn independently online, on a schedule that works for you.
- Scheduled Online · Example date — edit before launch Example self-paced instance. Edit the access details before launch.
Live in person
Join an instructor-led workshop at the published venue.
- Scheduled Frankfurt area (example venue) · Example date — edit before launch Example in-person instance. Edit the venue and date before launch.
Online webinar (Zoom)
Join a live, instructor-led session online using Zoom.
- Scheduled Zoom · Example date — edit before launch Example live Zoom instance. Edit the date before launch.
Enrolment
Purchase CRS03
Select a delivery type and course instance. When sales are open, secure payment is completed on Stripe and access is issued only after Stripe confirms payment.